Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruinsma

Showing results (791-800 of 963) with videos related to

Pageof 97
Sort By:
The Lancet. Public Health|October 8, 2019
Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient dataDongshan Zhu, Hsin-Fang Chung, Annette J Dobson, et al.
Annals of the Rheumatic Diseases|August 19, 2019
MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working groupWalter P Maksymowych, Robert Gw Lambert, Mikkel Østergaard, et al.
Annals of the Rheumatic Diseases|January 15, 2017
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritisDésirée van der Heijde, Sofia Ramiro, Robert Landewé, et al.
Rheumatology (Oxford, England)|March 24, 2022
The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritisMichael Nissen, Bénédicte Delcoigne, Daniela Di Giuseppe, et al.
NPJ Breast Cancer|February 18, 2022
Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancerKirsten G M Aspros, Jodi M Carter, Tanya L Hoskin, et al.
American Heart Journal|February 10, 2019
Early initiation of extracorporeal life support in refractory out-of-hospital cardiac arrest: Design and rationale of the INCEPTION trialMartine E Bol, Martje M Suverein, Roberto Lorusso, et al.
Plos Medicine|November 28, 2018
Relationships between intensity, duration, cumulative dose, and timing of smoking with age at menopause: A pooled analysis of individual data from 17 observational studiesDongshan Zhu, Hsin-Fang Chung, Nirmala Pandeya, et al.
EULAR Rheumatology Open|June 29, 2026
The impact of smoking and obesity on secukinumab effectiveness in psoriatic arthritis: real-world evidence from 1202 European patientsZohra Faizy Ahmadzay, Stylianos Georgiadis, Mikkel Østergaard, et al.
The Journal of Rheumatology|February 1, 2025
Predictors of Secukinumab Treatment Response and Continuation in Axial Spondyloarthritis: Results From the EuroSpA Research Collaboration NetworkMarion Pons, Stylianos Georgiadis, Merete Lund Hetland, et al.
RMD Open|September 20, 2020
Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaborationBrigitte Michelsen, Ulf Lindström, Catalin Codreanu, et al.
Pageof 97

Showing results (791-800 of 963) with videos related to

Sort By:
Pageof 97
The Lancet. Public Health|October 8, 2019
Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient dataDongshan Zhu, Hsin-Fang Chung, Annette J Dobson, et al.
Annals of the Rheumatic Diseases|August 19, 2019
MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working groupWalter P Maksymowych, Robert Gw Lambert, Mikkel Østergaard, et al.
Annals of the Rheumatic Diseases|January 15, 2017
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritisDésirée van der Heijde, Sofia Ramiro, Robert Landewé, et al.
Rheumatology (Oxford, England)|March 24, 2022
The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritisMichael Nissen, Bénédicte Delcoigne, Daniela Di Giuseppe, et al.
NPJ Breast Cancer|February 18, 2022
Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancerKirsten G M Aspros, Jodi M Carter, Tanya L Hoskin, et al.
American Heart Journal|February 10, 2019
Early initiation of extracorporeal life support in refractory out-of-hospital cardiac arrest: Design and rationale of the INCEPTION trialMartine E Bol, Martje M Suverein, Roberto Lorusso, et al.
Plos Medicine|November 28, 2018
Relationships between intensity, duration, cumulative dose, and timing of smoking with age at menopause: A pooled analysis of individual data from 17 observational studiesDongshan Zhu, Hsin-Fang Chung, Nirmala Pandeya, et al.
EULAR Rheumatology Open|June 29, 2026
The impact of smoking and obesity on secukinumab effectiveness in psoriatic arthritis: real-world evidence from 1202 European patientsZohra Faizy Ahmadzay, Stylianos Georgiadis, Mikkel Østergaard, et al.
The Journal of Rheumatology|February 1, 2025
Predictors of Secukinumab Treatment Response and Continuation in Axial Spondyloarthritis: Results From the EuroSpA Research Collaboration NetworkMarion Pons, Stylianos Georgiadis, Merete Lund Hetland, et al.
RMD Open|September 20, 2020
Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaborationBrigitte Michelsen, Ulf Lindström, Catalin Codreanu, et al.
Pageof 97